Johns Hopkins researchers will present results showing that tighter, dual testing standards work better for accurately distinguishing between new and old cases of HIV. Current testing standards are based on a single test called the serological testing algorithm for recent HIV seroconversion, or STARHS for short. STARHS relies on differentiating newly infected from chronically infected individuals based on the quantity, or levels, of antibodies to HIV present in patients blood. Normally, the antibody concentration to HIV increases over time during the first six months of infection. However, effective use of anti-retroviral therapy can depress viral counts in patients to undetectably low levels, which also lower the antibody-to-HIV concentration in the blood. This creates confusion for those responsible for monitoring new infections and spread of HIV. According to the researchers, large numbers of artificially "new" cases also have the potential to hamper measurements of how successful are global treatment efforts in Africa, where aid from the United States is set to make antiretroviral therapy more widely available.
The Hopkins team successfully determined new cases from old by adding the Affinity/Avidity test to the current STARHS protocol, the test widely used by the United States Centers for Disease Control and Prevention. This second test measures the strength of antibody-antigen binding in the immune systems response to HIV infection. An immature response from a new infection produces weak binding, whereas a mature infection involves strong binding. In a cross-sectional study of more than 1,500 patients showing up in the Hopkins Emergency Department from June to August 2001, the testing of blood samples by STARHS showed 11 cases of new infection, but dual testing with Affinity/Avidity showed only six. Information gathered from interviews with two of the five discrepant patients confirmed that these two were taking antiretroviral therapy, masking their old infection as new.
David March | EurekAlert!
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences